<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/local-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/local-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2006-12-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2006-12-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/local-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv/"},"url":"https://clinicaltree.github.io/posts/local-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv/"}</script><title>Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Local Toxicity of Hepatic Arterial Infusion of Hexokinase II Inhibitor, 3-Bromopyruvate In Vivo Investigation in Normal Rabbit Model</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1167584400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Dec 31, 2006 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Jung Min Chang M.D.</a> </em>, <em> <a href="">Jin Wook Chung M.D.</a> </em>, <em> <a href="">Hwan Jun Jae M.D.</a> </em>, <em> <a href="">Hong Eh M.D.</a> </em>, <em> <a href="">Kyu Ri Son M.D.</a> </em>, <em> <a href="">Ki Chang Lee M.D.</a> </em>, <em> <a href="">Jae Hyung Park M.D.</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1157 words"> <em>6 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>3-Bromopyruvate (3-BrPA), an hexokinase II inhibitor, is known to have high necrotic rate in hyperglycolytic liver tumor models without apparent damage to the normal liver parenchyma. The toxicity of intra-arterial delivery of 3-BrPA in various concentrations has not been specifically investigated using a normal rabbit model.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Twenty rabbits treated with intra-arterial 3-BrPA were divided into four groups according to its dose and infusion level: 1 mM at the left hepatic artery (group I), 5 mM at the left hepatic artery (group II), 25 mM at the left hepatic artery (group III), and 25 mM at the common hepatic artery (group IV). After selective catheterization, 30 ml of 3-BrPA was infused for 2 minutes. As a control group, five rabbits were treated with normal saline. During 1-week follow-up, toxicities were evaluated with blood laboratory results, mortality, and histopathologic examination.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>All 10 rabbits treated with 25 mM 3-BrPA and 2 rabbits treated with 5 mM 3-BrPA died within 3 days after treatment. In 10 of the 12 deaths, hemorrhagic pyloric or duodenal necrosis was noted. Hepatotoxicities on blood laboratory results were dose dependent but transient in the surviving rabbits.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Selective intra-arterial administration of 25 mM 3-BrPA can cause considerable toxicities not only in the liver but also in the gastrointestinal system and are dose dependent and can cause death in high doses.</p><p>Hepatocellular carcinoma (HCC) is the fifth most common cancer, and the third most common cause of cancer-related death in the world ( ). Because of the advanced stage of the disease and associated liver cirrhosis at its initial presentation, only a minority of patients are eligible for curative treatments such as surgical excision or local ablation therapies such as radiofrequency ablation and percutaneous ethanol injection ( ). Therefore, transcatheter arterial approach has been widely investigated as a palliative treatment for HCC, which includes hepatic arterial infusion chemotherapy and transcatheter arterial chemoembolization (TACE) ( ). Recently, survival benefit of TACE has been proved by prospective randomized clinical trial ( ). However, the therapeutic efficacy of TACE is still limited and deterioration of liver function is unavoidably associated.</p><p>As a new concept for anticancer therapy, blocking of cancer energy metabolism by selective hexokinase II inhibition has been proposed ( ). Hexokinase is the first-step enzyme of glucose metabolism. Among hexokinase isotypes, hexokinase II is overexpressed in tumor cells to produce ATP and cell building blocks for uncontrolled tumor overgrowth. Theoretically, selective inhibition of hexokinase II may lead to tumor necrosis without normal tissue damage ( ).</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="experimental-animal-and-study-design"><span class="mr-2">Experimental Animal and Study Design</span><a href="#experimental-animal-and-study-design" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="preparation-of-3-brpa-solution"><span class="mr-2">Preparation of 3-BrPA Solution</span><a href="#preparation-of-3-brpa-solution" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="procedures-for-intra-arterial-administration-of-3-brpa-and-normal-saline"><span class="mr-2">Procedures for Intra-arterial Administration of 3-BrPA and Normal Saline</span><a href="#procedures-for-intra-arterial-administration-of-3-brpa-and-normal-saline" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/0_1s20S1076633206005708.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/0_1s20S1076633206005708.jpg" alt="Figure 1, Typical celiac angiographic anatomy of a rabbit. 3-BrPA was infused at the left hepatic artery level (LHA) in groups I, II, and III and the control group. In group IV, 3-BrPA was infused in common hepatic artery (CHA). PHA, proper hepatic artery; RHA, right hepatic artery; GDA, gastroduodenal artery, pyloroduodenal branch ( arrowhead )." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="evaluation-of-hepatotoxicity"><span class="mr-2">Evaluation of Hepatotoxicity</span><a href="#evaluation-of-hepatotoxicity" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/1_1s20S1076633206005708.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/1_1s20S1076633206005708.jpg" alt="Figure 2, Postmortem examination after intra-arterial delivery of 25 mM 3-BrPA at common hepatic artery level. ( a ) Photograph obtained during autopsy reveals extensive hemorrhagic necrosis of the duodenum ( arrows ) and diffuse redness and swelling in gastric antrum. Discoloration of liver is also noted. ( b ) Photomicrograph of the liver shows prominent enlargement of cytoplasm of hepatocyte with hepatocyte necrosis (arrows) (original magnification, ×400)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/2_1s20S1076633206005708.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/2_1s20S1076633206005708.jpg" alt="Figure 3, Photomicrograph of the liver treated with intra-arterial delivery of 1 mM 3-BrPA in group I. No significant hepatocyte change is noted on microscopic examination (original magnification, ×200)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/3_1s20S1076633206005708.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/3_1s20S1076633206005708.jpg" alt="Figure 4, Dual-phase contrast-enhanced CT and microscopic appearance of the liver after intra-arterial delivery of 5 mM 3-BrPA in group II. ( a ) Contrast-enhanced CT in the same rabbit shows heterogeneous mottled enhancement of liver parenchyma on arterial phase. ( b ) In the portal phase, there are no focal lesions or abnormal enhancement in liver parenchyma. ( c ) Photomicrograph of histologic specimen shows focal cytoplasm enlargement with pale-colored hepatocyte (original magnification, ×400). The exact cause of diffuse mottled enhancement of the liver on arterial phase CT scan was not clarified." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/4_1s20S1076633206005708.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/LocalToxicityofHepaticArterialInfusionofHexokinaseIIInhibitor3BromopyruvateInVivoInvestigationinNormalRabbitModel/4_1s20S1076633206005708.jpg" alt="Figure 5, Comparison of plasma biochemicals between treated groups. ( a ) Aspartate aminotransferase (AST) levels (IU/L). ( b ) Alanine aminotransferase (ALT) levels (IU/L). ( c ) Total bilirubin levels (mg/dl). ( d ) Alkaline phosphatase levels (IU/L). e , Lactate dehydrogenase (LDH) levels (IU/L). Line graphs (displayed as mean values of enzymes in each group) show that plasma enzyme levels tended to increase for 1−3 days in variable extent depending on the doses of 3-BrPA infused. At 4 days after transarterial infusion, the enzyme levels of surviving animals return to pretreatment values in all groups. Circle , Control group, triangles , group I, and diamonds , group II." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion-1"><span class="mr-2">Conclusion</span><a href="#conclusion-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Montalto G., Cervello M., Giannitrapani L., et. al.: Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002; 963: pp. 13-20.</p><li><p>2. Parkin D.M., Bray F., Ferlay J., et. al.: Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer 2001; 94: pp. 153-156.</p><li><p>3. Venook A.P.: Treatment of hepatocellular carcinoma: Too many options?. J Clin Oncol 1994; 12: pp. 1323-1334.</p><li><p>4. Ramsey D.E., Kernagis L.Y., Soulen M.C., Geschwind J.F.: Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 2002; 13: pp. S211-S221.</p><li><p>5. Llovet J.M., Real M.I., Montana X., et. al.: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized controlled trial. Lancet 2002; 359: pp. 1734-1739.</p><li><p>6. Ko Y.H., Pedersen P.L., Geschwind J.F.: Glucose catabolism in the rabbit VX2 tumor model for liver cancer: Characterization and targeting hexokinase. Cancer Lett 2001; 173: pp. 83-91.</p><li><p>7. Bustamante E., Morris H.P., Pedersen P.L.: Energy metabolism of tumor cells. J Biol Chem 1981; 256: pp. 8699-8704.</p><li><p>8. Geschwind J.F., Ko Y.H., Torbenson M.S., et. al.: Novel therapy for liver cancer: Direct intra-arterial injection of a potent inhibitor of ATP production. Cancer Res 2002; 62: pp. 3909-3913.</p><li><p>9. Dang C.V., Semenza G.L.: Oncogenic alterations of metabolism. Trends Biochem Sci 1999; 24: pp. 68-72.</p><li><p>10. Zasshi Y.: Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells. Yakugaku Zasshi 2000; 120: pp. 657-666.</p><li><p>11. Lee M.G., Pedersen P.L.: Glucose metabolism in cancer: Importance of transcription factor-DNA interactions within a shirt segment of the proximal region of type II hexokinase promoter. J Biol Chem 2003; 278: pp. 41047-41058.</p><li><p>12. Ko Y.H., McFadden B.A.: Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate. Arch Biochem Biophys 1990; 278: pp. 373-380.</p><li><p>13. Gwak G.Y., Yoon J.H., Kim K.M., et. al.: Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 2005; 42: pp. 358-364.</p><li><p>14. Ko Y.H., Smith B.L., Wang Y., et. al.: Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun 2004; 324: pp. 269-275.</p><li><p>15. Liu D.M., Salem R., Bui J.T., et. al.: Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 2005; 16: pp. 911-935.</p><li><p>16. Song S.Y., Chung J.W., Lim H.G., et. al.: Nonhepatic arteries originating from the hepatic arteries: Angiographic analysis in 250 patients. J Vasc Interv Radiol 2006; 17: pp. 461-469.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-14/'>Volume 14</a>, <a href='/categories/issue-1/'>Issue 1</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Local%20Toxicity%20of%20Hepatic%20Arterial%20Infusion%20of%20Hexokinase%20II%20Inhibitor,%203-Bromopyruvate%20In%20Vivo%20Investigation%20in%20Normal%20Rabbit%20Model%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flocal-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Local%20Toxicity%20of%20Hepatic%20Arterial%20Infusion%20of%20Hexokinase%20II%20Inhibitor,%203-Bromopyruvate%20In%20Vivo%20Investigation%20in%20Normal%20Rabbit%20Model%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flocal-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flocal-toxicity-of-hepatic-arterial-infusion-of-hexokinase-ii-inhibitor-3-bromopyruvate-in-vivo-inv%2F&text=Local%20Toxicity%20of%20Hepatic%20Arterial%20Infusion%20of%20Hexokinase%20II%20Inhibitor,%203-Bromopyruvate%20In%20Vivo%20Investigation%20in%20Normal%20Rabbit%20Model%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/abstracts-of-funded-national-institutes-of-health-grants/"><div class="card-body"> <em class="small" data-ts="1167584400" data-df="ll" > Dec 31, 2006 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Abstracts of Funded National Institutes of Health Grants</h3><div class="text-muted small"><p> The following abstracts of diagnostic radiology research and training grants funded by the National Institutes of Health (NIH) were awarded to principal investigators (PIs) whose primary appointmen...</p></div></div></a></div><div class="card"> <a href="/posts/acute-abdomen/"><div class="card-body"> <em class="small" data-ts="1167584400" data-df="ll" > Dec 31, 2006 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Acute Abdomen</h3><div class="text-muted small"><p> Rationale and Objectives We sought to assess retrospectively the added value of coronal reformations from isotropic voxels obtained with 64-slice multidetector row computed tomography (CT) of the ...</p></div></div></a></div><div class="card"> <a href="/posts/amaurosis-fugax-secondary-to-imaging-methods-of-mri-scan/"><div class="card-body"> <em class="small" data-ts="1167584400" data-df="ll" > Dec 31, 2006 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Amaurosis Fugax Secondary to Imaging Methods of MRI Scan</h3><div class="text-muted small"><p> Magnetic resonance imaging (MRI) scans are frequently and routinely used to view the orbit; however, problems with imaging quality can arise from the patient’s voluntary ocular movements. Several n...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/expense-reduction-through-distance-learning/" class="btn btn-outline-primary" prompt="Older"><p>Expense Reduction Through Distance Learning</p></a> <a href="/posts/modes-of-information-delivery-in-radiologic-anatomy-education-impact-on-student-performance/" class="btn btn-outline-primary" prompt="Newer"><p>Modes of Information Delivery in Radiologic Anatomy Education Impact on Student Performance</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
